Using (1,3)‐β‐D‐glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis

Wako β‐D ‐glucan assay can be used to measure serum β‐D ‐glucan in Sudanese patients to aid with diagnosis of eumycetoma caused by Madurella mycetomatis

(2022) Bertrand Nyuykonge et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

A Negative (1,3)-β-D-Glucan Result Alone Is Not Sufficient to Rule Out a Diagnosis of Pneumocystis Pneumonia in Patients With Hematological Malignancies

(2021) Céline Damiani et al.   Frontiers in Microbiology

Madurella mycetomatis causing eumycetoma medical treatment: The challenges and prospects

(2020) Lamis Y. M. Elkheir et al.   PLoS Neglected Tropical Diseases

Development of E1224 by leveraging a strategic partnership for the medicines creation against neglected tropical diseases

(2020) Katsura Hata   PARASITOLOGY INTERNATIONAL

Detection of (1→3)-β-d-Glucan in Eumycetoma Patients

(2016) Ahmed H. Fahal et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Mycetoma: a unique neglected tropical disease

(2016) Eduard E Zijlstra et al.   LANCET INFECTIOUS DISEASES

Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases

(2016) Cécile Angebault et al.   Open Forum Infectious Diseases

The Mycetoma Knowledge Gap: Identification of Research Priorities

(2014) Wendy W. J. van de Sande et al.   PLoS Neglected Tropical Diseases

Mycetoma Medical Therapy

(2014) Oliverio Welsh et al.   PLoS Neglected Tropical Diseases

β-Glucan Antigenemia Anticipates Diagnosis of Blood Culture–Negative Intraabdominal Candidiasis

(2013) Frederic Tissot et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Global Burden of Human Mycetoma: A Systematic Review and Meta-analysis

(2013) Wendy W. J. van de Sande   PLoS Neglected Tropical Diseases

(1,3)- -D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis

(2012) S. Jaijakul et al.   CLINICAL INFECTIOUS DISEASES

 -Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3)

(2011) F. Lamoth et al.   CLINICAL INFECTIOUS DISEASES

Kinetics of Serum β-D-Glucan after Pneumocystis Pneumonia Treatment in Patients with AIDS

(2011) Michiko Koga et al.   INTERNAL MEDICINE

The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis

(2011) A.H. Fahal et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

Serum (1→3) β‐d‐Glucan as a Noninvasive Adjunct Marker for the Diagnosis ofPneumocystisPneumonia in Patients with AIDS

(2009) Tamayo Watanabe et al.   CLINICAL INFECTIOUS DISEASES

Serum (1-3)- -D-Glucan as a Tool for Diagnosis of Pneumocystis jirovecii Pneumonia in Patients with Human Immunodeficiency Virus Infection or Hematological Malignancy

(2009) S. Desmet et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The effects of β-glucan on human immune and cancer cells

(2009) Godfrey Chan et al.   Journal of Hematology & Oncology